U.S. Markets closed

FSD Pharma Inc. (HUGE.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
2.3800+0.0600 (+2.59%)
At close: 3:53PM EST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.3200
Open2.3500
Bid2.3700 x 0
Ask2.4400 x 0
Day's Range2.2500 - 2.4300
52 Week Range1.7000 - 15.1000
Volume44,435
Avg. Volume30,947
Market Cap45.605M
Beta (5Y Monthly)1.23
PE Ratio (TTM)N/A
EPS (TTM)-5.8400
Earnings DateNov 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update
    Business Wire

    FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update

    FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) ("FSD Pharma" or the "Company") today announced its financial results for the third quarter ending September 30, 2020 and provided a corporate update. The filing is available on SEDAR.

  • FSD Pharma Announces Settlement of Class Action Proceeding
    Business Wire

    FSD Pharma Announces Settlement of Class Action Proceeding

    FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) ("FSD Pharma" or the "Company") today announced that, subject to court certification and other customary conditions, it has entered into a definitive settlement agreement (the "Settlement Agreement") with respect to the class action litigation commenced by a plaintiff shareholder in the Ontario Superior Court of Justice in February 2019 relating to the build-out of its facility in Cobourg, Ontario (the "Settled Action").

  • FSD Pharma Inc. Announces Closing of US$9.5 Million Registered Direct Offering
    Business Wire

    FSD Pharma Inc. Announces Closing of US$9.5 Million Registered Direct Offering

    FSD Pharma Inc. (Nasdaq: HUGE) ("FSD Pharma" or the "Company"), today announced the closing of previously announced definitive agreements with investors for the purchase and sale of 4,318,179 Class B Subordinate Voting Shares of the Company ("Shares") and warrants to purchase 3,454,543 Shares (collectively, the "Securities") at a purchase price of US$2.20 per Share in a registered direct offering. The warrants have an exercise price of US$2.60 per Share, are immediately exercisable and expire five years from the date of issuance.